Global Vagal Nerve Stimulation (VNS) Market Size, Share, Forecast Report, 2020-2027

Vagal nerve stimulation or vagus nerve stimulation (VNS) is a treatment method that involves delivering electrical impulses to the vagus nerve. Vegas nerve acts as a translator between gut and brain. Gut uses the vagus nerve like a walkie-talkie and translates signals via electric impulses, which called action potentials. VNS treatment is used for certain types of intractable epilepsy, depression, and others. In most common cases, overstimulation of the vagus nerve causes fainting. Vagus nerve stimulation is a procedure, which involves implantation of a device that stimulates the vagus nerve with electrical impulses. This device is normally implanted under the skin below the patient’s clavicle. Lead wires from the generator are excavated up to the patient’s neck and wrapped around the left vagus nerve at the carotid sheath, where it delivers electrical impulses to the nerve. After successfully implanted, the generator sends electric impulses to the vagus nerve at a regular intervals.

Vagal nerve stimulation (VNS), may offer hope for patients who don’t improve with conventional depression treatment. A small battery-powered device like a pacemaker is inserted under the skin in the neck, from where it emits pulses of weak electrical current to stimulate part of the vagus nerve.

Increasing prevalence of neurological disorders, increasing investment of biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drives the growth of the market. Moreover, favorable reimbursement policies, increased application and significant investments in development of new technologies for the treatment of epilepsy, and other cardiac indications will fuel the market growth during the forecast period.
Key Players

Some of key the players in the market are LivaNova PLC (UK), EnteroMedics Inc. (US), ElectroCore Medical LLC (US), Boston Scientific Corporation (US), Cyberonics, Inc. (US), NeuroMetrix, Inc.(US), ImThera Medical (US), and Inspire Medical Systems, Inc.(US)

Segmentations

The global vagal nerve stimulation market has been segmented on the basis of products, application, and end user.

On the basis of products, the market is segmented into implantable VNS devices and external VNS devices.

On the basis of application, the market is segmented into depression, epilepsy, migraine, and others.

On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and others.